American Skin Association (ASA) is accepting applications for support of research in melanoma and skin cancer
DEADLINE AND APPLICATION FORMS:
Instructions and the online application are posted on our website: americanskin.org. The deadline for receipt of applications is Friday, May 22, 2026, at 11:59 PM EST. Incomplete applications will not be considered.
SELECTION PROCESS: Selection of the recipients will be made in July 2026 by ASA’s Medical Advisory Committee. Funding will begin in September 2026. Please note: No cost extensions will not be granted.
Common areas:
👉 Non-dermatology topics → low success probability
👉 Key question:
“Will this improve real-world skin health outcomes?”
👉 Pure molecular/basic skin biology without clinical application is generally less competitive.
One of the strongest recurring themes:
👉 Mechanistically grounded barrier science aligns strongly with brand identity.
👉 Community and educational value are important advantages.
Successful projects usually involve:
👉 Clinical credibility significantly improves competitiveness.
👉 Projects addressing underserved populations are increasingly favored.
Competitive studies often measure:
👉 Practical measurable outcomes matter greatly.
👉 Trusted clinical partnerships strengthen proposals.
Studies aligned with:
tend to fit strategically better.
👉 Alignment with skincare science themes improves funding likelihood.
Strong projects often include:
👉 Dissemination potential is highly valued.
Competitive themes include:
👉 Prevention-oriented skincare science aligns well with brand strategy.
🔥 Highest impact factors:
⚖️ Major differentiators:
📌 Supporting factors:
Compared to NIH or pharmaceutical dermatology funders:
👉 Winning formula:
Barrier-focused dermatology project + practical patient benefit + strong clinical relevance + educational/community impact
✔️ What wins:
❌ What struggles:
Applicants must be working actively in areas related to melanoma and skin cancer. Funds may be used for support of a new or ongoing research/clinical investigation project. There is no age requirement. However, applicants without prior funding, who are in a formative stage of their career, or who are undergoing a mid-career research change, will be given preference.
Sponsor Institute/Organizations: CeraVe
Sponsor Type: Corporate/Non-Profit
Address: 10 Hudson St, New York City, New York 10001
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
May 22, 2026
May 22, 2026
$15,000
Affiliation: CeraVe
Address: 10 Hudson St, New York City, New York 10001
Website URL: https://www.americanskin.org/research/pdf/2026-ASA-Research-Grant-in-Melanoma-Guideline.pdf
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.